Corporate report

UKHSA Pathogen Genomics Strategy

The strategy will set the direction for how we will invest in and transform the use of pathogen genomics in response to infectious public health threats.

From:
UK Health Security Agency
Published
24 January 2024

Documents

UKHSA Pathogen Genomics Strategy

PDF, 6.28 MB, 13 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The UK Health Security Agency (UKHSA) is responsible for protecting public health in the UK, supporting global efforts to improve public health and has been world-leading at implementing pathogen genomics services to do this.

The UKHSA Pathogen Genomics Strategy will:

  • target international, national and regional public health priorities
  • develop accredited, resilient genomic services for target priority pathogens
  • communicate information that leads to improved clinical care and outcomes for individual patients
  • provide demonstrable public health benefit
  • deliver a cost-effective service, to provide value for money
  • share infrastructure and expertise throughout and beyond the organisation

This strategy sets out how we will implement a programmatic approach to pathogen genomics in the future. This includes governance and oversight mechanisms for reporting the impact of this work upwards and outwards, staff training and retention, cross-team working, and accountability to ensure the benefit to public health is maximised.

Updates to this page

Published 24 January 2024

Sign up for emails or print this page